SCOTUS Takes on Scope of Enablement Inquiry in Amgen v. Sanofi: Implications for Pharma/ Biotech and Beyond
USPTO Webinar on ‘Robust and Reliable Patent Rights’ Underscores Pressure on Office to Respond to Public Scrutiny of Examination Practices